Literature DB >> 33971931

Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-α.

Wenhui Huang1,2, Hongjin Liu1, Yichao Pan1, Hongwei Yang1, Jing Lin1, Hui Zhang3.   

Abstract

BACKGROUND: This study aimed to explore whether the mechanical stretching-induced expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in pulmonary veins occurred through the stretch-activated channel (SAC)/ mitogen-activated protein kinases (MAPKs) pathway.
METHODS: Sixty male Sprague-Dawley rats were divided into three sham groups and seven model groups. A metal clip was placed on the ascending aorta in the model group to establish PH-LHD rat model. The sham group received a similar operation without ascending aorta clamped. On day 25, pulmonary vein was given mechanical stretching with 0 g, 2.0 g tension in two model groups and two sham groups. Another four model groups were given 2.0 g tension after MAPKs pathway inhibitors soaked. The last sham group and model group rats' pulmonary veins, pulmonary artery and lung tissues were obtained on day 35. Pulmonary vein, pulmonary artery and lung tissue were evaluated by echocardiography, HE staining, immunohistochemistry and western blotting respectively.
RESULTS: On day 25, left heart weight, right ventricular pressure (35.339 cmH2O) and left atrial pressure (13.657 cmH2O) were increased in model group than those in sham group. Echocardiography showed left heart failure in the PH-LHD group (Interventrieular septum dimension 1.716 mm, left ventricular internal end diastolic dimension 4.888 mm, left ventricular posterior wall thickness in diastole 1.749 mm, ejection fraction 76.917%). But there was no difference in lung tissue between the sham group and PH-LHD group as showed by HE staining. Our results showed that the expression of IL-6 and TNF-α was highly expressed in PH-LHD rats' serum and pulmonary vein, which were further increased after 2.0 g tension was given and were decreased after SAC/MAPKs inhibitors treatment. Meanwhile, on day 25, immunohistochemistry analysis showed the expression of IL-6 and TNF-α was higher in the PH-LHD rats' pulmonary vein than that in pulmonary artery and lung tissue, and these expressions in pulmonary vein of PH-LHD group were also higher than that in sham group. However, on day 35, IL-6 and TNF-α were all increased in the pulmonary veins, arteries and lung tissues. Besides, our results uncovered that SAC/MAPKs pathway were upregulating in PH-LHD rats' pulmonary vein.
CONCLUSION: In conclusion, pulmonary vein mechanical stretching exacerbated PH-LHD possibly through the SAC/MAPKs pathway and upregulating expression of IL-6 and TNF-α.

Entities:  

Keywords:  IL-6; MAPKs; Pulmonary hypertension due to left heart disease; Pulmonary vein; TNF-α

Year:  2021        PMID: 33971931     DOI: 10.1186/s13019-021-01471-5

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  23 in total

1.  Mechanical stretch aggravates aortic dissection by regulating MAPK pathway and the expression of MMP-9 and inflammation factors.

Authors:  Yunnan Hu; Lin Lu; Zhihuang Qiu; Qiuyu Huang; Yinhai Chen; Liangwan Chen
Journal:  Biomed Pharmacother       Date:  2018-10-03       Impact factor: 6.529

Review 2.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

3.  Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension.

Authors:  Gopinath Sutendra; Peter Dromparis; Sébastien Bonnet; Alois Haromy; Michael S McMurtry; R Chris Bleackley; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2011-08-02       Impact factor: 4.599

4.  Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes.

Authors:  Massimiliano Palazzini; Fabio Dardi; Alessandra Manes; Maria L Bacchi Reggiani; Enrico Gotti; Andrea Rinaldi; Alessandra Albini; Enrico Monti; Nazzareno Galiè
Journal:  Eur J Heart Fail       Date:  2017-05-02       Impact factor: 15.534

5.  TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.

Authors:  K Zhang; M Gharaee-Kermani; B McGarry; D Remick; S H Phan
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.

Authors:  Moira Hagen; Karen Fagan; Wolfgang Steudel; Michelle Carr; Kirk Lane; David M Rodman; James West
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-02-23       Impact factor: 5.464

7.  Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction.

Authors:  Ahmed U Fayyaz; William D Edwards; Joseph J Maleszewski; Ewa A Konik; Hilary M DuBrock; Barry A Borlaug; Robert P Frantz; Sarah M Jenkins; Margaret M Redfield
Journal:  Circulation       Date:  2017-12-15       Impact factor: 29.690

Review 8.  The pathophysiology of pulmonary hypertension in left heart disease.

Authors:  Siegfried Breitling; Krishnan Ravindran; Neil M Goldenberg; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-21       Impact factor: 5.464

9.  Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.

Authors:  Laurent Savale; Ly Tu; Dominique Rideau; Mohamed Izziki; Bernard Maitre; Serge Adnot; Saadia Eddahibi
Journal:  Respir Res       Date:  2009-01-27

10.  Interleukin-6 trans-signaling contributes to chronic hypoxia-induced pulmonary hypertension.

Authors:  Levi D Maston; David T Jones; Wieslawa Giermakowska; Thomas C Resta; Juan Ramiro-Diaz; Tamara A Howard; Nikki L Jernigan; Lindsay Herbert; Anna A Maurice; Laura V Gonzalez Bosc
Journal:  Pulm Circ       Date:  2018-05-16       Impact factor: 3.017

View more
  3 in total

Review 1.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

2.  Correction to: Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/ MAPK pathway and the expression of IL-6 and TNF-α.

Authors:  Wenhui Huang; Hongjin Liu; Yichao Pan; Hongwei Yang; Jing Lin; Hui Zhang
Journal:  J Cardiothorac Surg       Date:  2021-06-09       Impact factor: 1.637

Review 3.  Animal models of pulmonary hypertension due to left heart disease.

Authors:  Shao-Fei Liu; Yi Yan
Journal:  Animal Model Exp Med       Date:  2022-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.